FDA Approved: PANTOPRAZOLE — Supplemental Application (NorthStar RxLLC)

View source ↗

Summary

FDA approved a supplemental application for pantoprazole by NorthStar RxLLC under ANDA077619.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Duodenal Ulcer
• Erosive Esophagitis
• Gastric Ulcer
• Gastroesophageal Reflux Disease
• Helicobacter Pylori Infection
• Peptic Ulcer Disease
• Zollinger-ellison Syndrome

Drugs mentioned

• Pantoprazole (pantoprazole)

Snippet

SUPPL AP for PANTOPRAZOLE (PANTOPRAZOLE)